PSMD3 and chronic myelogenous leukemia, BCR-ABL1 positive: Altogether, these data confirm that PSMD1 and PSMD3 mRNA and protein are differentially expressed in multiple types of human cancers, similar to our recent findings in CML disease progression and TKI resistance [31].